Core-002
- Institution
- Seattle Children's Hospital, WA
- Principal investigator
- Kenneth D Stuart
- Funding
- $972K
- Duration
- 2017–2027
Moonbase score
Still being scored
Abstract
The Clinical Core will continue to provide the leadership and expertise in clinical infectious diseases and human subjects research to support the HIPC3 and our collaboration’s three scientific projects focused on comprehensive immune analysis of malaria, HIV-1 and SARS-CoV-2 prevention and infection. Based within the Vaccine and Infectious Disease Division at Fred Hutchinson Cancer Research Center, the Clinical Core will establish, conduct and oversee clinical cohort observational studies and human immunology studies nested within clinical vaccine trials in order to obtain longitudinal specimens for deep immune profiling investigations. To accomplish our goals, we propose to provide the clinical infrastructure, leadership, expertise and to conduct human subjects research in infectious diseases on behalf of our HIPC3 Collaboration through observational studies and sub-studies nested within existing and future clinical trials. We also aim to design, develop, implement and maintain well-curated clinical cohorts and vaccine trial sub-studies to acquire specimens for immune profiling studies relevant to malaria, HIV-1 and SARS-CoV-2, either during or after infection, or before and after immunization.
Research team
- Margaret Juliana McelrathPI
- Kenneth D StuartPI
- Troy R TorgersonPI
LOADING MOONBASE SCORE
Questions for Seattle Children's Hospital
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · University of California, San FranciscoNot yet scored
Primary Immune Deficiency Treatment Consortium (PIDTC): A resource to drive scientific and clinical advances related to the treatment of inborn errors of immunity
Christopher Craig Dvorak · $21K · 2025–2029
- NIH · University of California, San FranciscoNot yet scored
Primary Immune Deficiency Treatment Consortium (PIDTC): A resource to drive scientific and clinical advances related to the treatment of inborn errors of immunity
Christopher Craig Dvorak · $1.7M · 2024–2029
- NIH · Seattle Children's HospitalNot yet scored
Collective Responses to Malaria Vaccination
Kenneth D Stuart · $679K · 2022–2027